Understanding BI-RADS Categories (0–5)
Overview
After a mammogram, ultrasound, or breast MRI, your radiology report may include a BI-RADS category. BI-RADS stands for Breast Imaging Reporting and Data System, a standardized system developed to help radiologists communicate findings clearly and consistently. These categories help guide recommendations for follow-up care, additional imaging, or biopsy when needed.
It is important to understand that a BI-RADS category is not a diagnosis. It is a way of describing imaging findings and the recommended next steps.
BI-RADS 0 — Additional Imaging Needed
A BI-RADS 0 result means the radiologist needs more information before making a final assessment.
This does not mean cancer is present. It simply means:
-
- Additional mammogram views may be needed to help
- Prior imaging may need to be compared
- An ultrasound or other imaging study may help clarify the finding
BI-RADS 0 is common, especially with:
-
- First-time mammograms
- Dense breast tissue
- Areas that are difficult to fully evaluate on initial images
What usually happens next?
You may be asked to return for additional imaging so the radiologist can further assess to complete the evaluation.
BI-RADS 1 — Negative / Normal
A BI-RADS 1 assessment means no abnormal findings were seen.
This indicates:
-
- No masses
- No suspicious calcifications
- No concerning abnormalities on the imaging study
Recommendation
Continue routine screening based on your provider’s recommendations and screening guidelines.
BI-RADS 2 — Benign Finding
A BI-RADS 2 result means a non-cancerous finding was identified.
Examples may include:
-
- Simple cysts
- Benign calcifications
- Intramammary lymph nodes
- Stable benign findings seen on prior imaging
These findings are considered harmless and do not suggest cancer.
Recommendation
Continue routine screening.
BI-RADS 3 — Probably Benign
BI-RADS 3 means the finding is considered probably benign, with a very low chance of cancer.
In this category:
-
- The finding does not look suspicious
- Short-term follow-up imaging is recommended to confirm stability over time
Important to Know
The estimated chance of malignancy in this category is very low (typically less than 2%). Most BI-RADS 3 findings remain stable and are ultimately confirmed to be benign.
Recommendation
Follow-up imaging is usually recommended in several months to track stability, typically over 2 years.
BI-RADS 4 — Suspicious Abnormality
BI-RADS 4 means the finding has features that are suspicious enough to recommend a biopsy.
This category covers a wide range of findings, and many BI-RADS 4 biopsies ultimately turn out to be benign.
Important to Know About “Likelihood of Malignancy”
Radiology reports may include wording such as:
- “Suspicious”
- “Likelihood of malignancy”
- “Probability of malignancy”
These terms are part of standardized federal and professional reporting guidelines used nationwide.
They are intended to describe how an imaging finding appears radiographically — not to state that cancer is definitely present.
A recommendation for biopsy is made because imaging alone cannot provide a definitive diagnosis.
Recommendation
A tissue biopsy is generally recommended to determine exactly what the finding represents.
BI-RADS 5 — Highly Suggestive of Malignancy
BI-RADS 5 means the imaging finding has characteristics that are highly concerning for cancer.
Although the likelihood of malignancy is considered high in this category, imaging alone still cannot provide a final diagnosis.
Important to Remember
Even with BI-RADS 5 findings:
-
- A biopsy is still required for confirmation
- Only pathology can make a definitive diagnosis and is required to help determine next steps for a surgeon
Recommendation
Prompt biopsy and consultation with your healthcare team are recommended.
Understanding the Phrase “Likelihood of Malignancy”
Patients are often understandably concerned when they see terms like:
-
- “Likelihood of malignancy”
- “Suspicious for malignancy”
- “Highly suggestive of malignancy”
These phrases are required as part of standardized reporting guidelines and are used to communicate how imaging findings compare to known patterns.
They do not mean:
-
- Cancer has already been diagnosed
- The finding is definitely cancer